Hikma Pharmaceuticals Plc Stock Market Value
| HKMPF Stock | USD 22.33 1.92 7.92% |
| Symbol | Hikma |
Hikma Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hikma Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hikma Pharmaceuticals.
| 01/18/2024 |
| 04/17/2024 |
If you would invest 0.00 in Hikma Pharmaceuticals on January 18, 2024 and sell it all today you would earn a total of 0.00 from holding Hikma Pharmaceuticals PLC or generate 0.0% return on investment in Hikma Pharmaceuticals over 90 days. Hikma Pharmaceuticals is related to or competes with Willamette Valley, Molson Coors, Keurig Dr, BCE, Ambev SA, Duckhorn Portfolio, and Vita Coco. Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharma... More
Hikma Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hikma Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hikma Pharmaceuticals PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 14.23 | |||
| Value At Risk | (3.05) | |||
| Potential Upside | 2.55 |
Hikma Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hikma Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hikma Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Hikma Pharmaceuticals historical prices to predict the future Hikma Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.29) | |||
| Treynor Ratio | (0.22) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hikma Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hikma Pharmaceuticals PLC Backtested Returns
Hikma Pharmaceuticals PLC holds Efficiency (Sharpe) Ratio of -0.0744, which attests that the entity had a -0.0744% return per unit of risk over the last 3 months. Hikma Pharmaceuticals PLC exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hikma Pharmaceuticals' Standard Deviation of 1.93, market risk adjusted performance of (0.21), and Risk Adjusted Performance of (0.04) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.69, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hikma Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Hikma Pharmaceuticals is expected to be smaller as well. Hikma Pharmaceuticals PLC has an expected return of -0.14%. Please make sure to check out Hikma Pharmaceuticals treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Hikma Pharmaceuticals PLC performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.68 |
Good predictability
Hikma Pharmaceuticals PLC has good predictability. Overlapping area represents the amount of predictability between Hikma Pharmaceuticals time series from 18th of January 2024 to 3rd of March 2024 and 3rd of March 2024 to 17th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hikma Pharmaceuticals PLC price movement. The serial correlation of 0.68 indicates that around 68.0% of current Hikma Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.37 |
Hikma Pharmaceuticals PLC lagged returns against current returns
Autocorrelation, which is Hikma Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hikma Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Hikma Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Hikma Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hikma Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hikma Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hikma Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hikma Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Hikma Pharmaceuticals Lagged Returns
When evaluating Hikma Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hikma Pharmaceuticals pink sheet have on its future price. Hikma Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hikma Pharmaceuticals autocorrelation shows the relationship between Hikma Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Hikma Pharmaceuticals PLC.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Hikma Pharmaceuticals Correlation, Hikma Pharmaceuticals Volatility and Hikma Pharmaceuticals Alpha and Beta module to complement your research on Hikma Pharmaceuticals. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Hikma Pink Sheet analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Hikma Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.